Loading…

Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer

To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2006-09, Vol.119 (6), p.1412-1418
Main Authors: Hermsen, Brenda B.J., van Diest, Paul J., Berkhof, Johannes, Menko, Fred H., Gille, Johan J.P., Piek, Jurgen M.J., Meijer, Sybren, Winters, Henri A.H., Kenemans, Peter, Mensdorff‐Pouilly, Silvia von, Verheijen, René H.M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3
cites cdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3
container_end_page 1418
container_issue 6
container_start_page 1412
container_title International journal of cancer
container_volume 119
creator Hermsen, Brenda B.J.
van Diest, Paul J.
Berkhof, Johannes
Menko, Fred H.
Gille, Johan J.P.
Piek, Jurgen M.J.
Meijer, Sybren
Winters, Henri A.H.
Kenemans, Peter
Mensdorff‐Pouilly, Silvia von
Verheijen, René H.M.
description To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ijc.21988
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68762931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17241190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EokvhwB9AvoDoIe3YSZzkiFYUilbiAudo4oy7Lk682Nmu-pP4lzi7kdoL4mTZ87335HmMvRVwKQDklb3Tl1I0df2MrQQ0VQZSlM_ZKs0gq0SuztirGO8AhCiheMnOhFKiFFCt2J-NP_BdoHt0NGri3vCP6XrBB3T2dsRx4o6i9WPkduTTlngXCOPEcez51t5un4oXwt9jeDgC1-ic31lM7_vuOD_4gUaOE99SoN5OM3m0CTb-mtOf2M8-s1ZjMg-v2QuDLtKb5TxnP68__1h_zTbfv9ysP20yXaQVZKoEJTuADrTWCpWp-0YVuiygN7VsZN7rAgnLMm-MqoxEo1DIGqtZTmWXn7MPJ99d8L_3FKd2sFGTcziS38dW1ZWSTS7-C4pKFkI0kMCLE6iDjzGQaXfBDunnrYB2LrBNBbbHAhP7bjHddwP1j-TSWALeLwBGjc6EtBwbH7kaZKUgT9zViTtYRw__Tmxvvq1P0X8B6jGzaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17241190</pqid></control><display><type>article</type><title>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Hermsen, Brenda B.J. ; van Diest, Paul J. ; Berkhof, Johannes ; Menko, Fred H. ; Gille, Johan J.P. ; Piek, Jurgen M.J. ; Meijer, Sybren ; Winters, Henri A.H. ; Kenemans, Peter ; Mensdorff‐Pouilly, Silvia von ; Verheijen, René H.M.</creator><creatorcontrib>Hermsen, Brenda B.J. ; van Diest, Paul J. ; Berkhof, Johannes ; Menko, Fred H. ; Gille, Johan J.P. ; Piek, Jurgen M.J. ; Meijer, Sybren ; Winters, Henri A.H. ; Kenemans, Peter ; Mensdorff‐Pouilly, Silvia von ; Verheijen, René H.M.</creatorcontrib><description>To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.21988</identifier><identifier>PMID: 16615107</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Biological and medical sciences ; BRCA1/2 ; breast ; Breast Neoplasms - genetics ; Breast Neoplasms - prevention &amp; control ; Breast Neoplasms - surgery ; Fallopian Tube Neoplasms - genetics ; Fallopian Tube Neoplasms - prevention &amp; control ; Fallopian Tube Neoplasms - surgery ; Female ; Female genital diseases ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Gynecology. Andrology. Obstetrics ; Humans ; Mastectomy ; Medical sciences ; Middle Aged ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - prevention &amp; control ; Ovarian Neoplasms - surgery ; Ovariectomy ; ovary ; premalignant lesions ; Prevalence ; Risk Factors ; Tumors</subject><ispartof>International journal of cancer, 2006-09, Vol.119 (6), p.1412-1418</ispartof><rights>Copyright © 2006 Wiley‐Liss, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</citedby><cites>FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18027603$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16615107$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermsen, Brenda B.J.</creatorcontrib><creatorcontrib>van Diest, Paul J.</creatorcontrib><creatorcontrib>Berkhof, Johannes</creatorcontrib><creatorcontrib>Menko, Fred H.</creatorcontrib><creatorcontrib>Gille, Johan J.P.</creatorcontrib><creatorcontrib>Piek, Jurgen M.J.</creatorcontrib><creatorcontrib>Meijer, Sybren</creatorcontrib><creatorcontrib>Winters, Henri A.H.</creatorcontrib><creatorcontrib>Kenemans, Peter</creatorcontrib><creatorcontrib>Mensdorff‐Pouilly, Silvia von</creatorcontrib><creatorcontrib>Verheijen, René H.M.</creatorcontrib><title>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>BRCA1/2</subject><subject>breast</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - prevention &amp; control</subject><subject>Breast Neoplasms - surgery</subject><subject>Fallopian Tube Neoplasms - genetics</subject><subject>Fallopian Tube Neoplasms - prevention &amp; control</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Genes, BRCA1</subject><subject>Genes, BRCA2</subject><subject>Genetic Predisposition to Disease</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mastectomy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - prevention &amp; control</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Ovariectomy</subject><subject>ovary</subject><subject>premalignant lesions</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Tumors</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv1DAQhS0EokvhwB9AvoDoIe3YSZzkiFYUilbiAudo4oy7Lk682Nmu-pP4lzi7kdoL4mTZ87335HmMvRVwKQDklb3Tl1I0df2MrQQ0VQZSlM_ZKs0gq0SuztirGO8AhCiheMnOhFKiFFCt2J-NP_BdoHt0NGri3vCP6XrBB3T2dsRx4o6i9WPkduTTlngXCOPEcez51t5un4oXwt9jeDgC1-ic31lM7_vuOD_4gUaOE99SoN5OM3m0CTb-mtOf2M8-s1ZjMg-v2QuDLtKb5TxnP68__1h_zTbfv9ysP20yXaQVZKoEJTuADrTWCpWp-0YVuiygN7VsZN7rAgnLMm-MqoxEo1DIGqtZTmWXn7MPJ99d8L_3FKd2sFGTcziS38dW1ZWSTS7-C4pKFkI0kMCLE6iDjzGQaXfBDunnrYB2LrBNBbbHAhP7bjHddwP1j-TSWALeLwBGjc6EtBwbH7kaZKUgT9zViTtYRw__Tmxvvq1P0X8B6jGzaw</recordid><startdate>20060915</startdate><enddate>20060915</enddate><creator>Hermsen, Brenda B.J.</creator><creator>van Diest, Paul J.</creator><creator>Berkhof, Johannes</creator><creator>Menko, Fred H.</creator><creator>Gille, Johan J.P.</creator><creator>Piek, Jurgen M.J.</creator><creator>Meijer, Sybren</creator><creator>Winters, Henri A.H.</creator><creator>Kenemans, Peter</creator><creator>Mensdorff‐Pouilly, Silvia von</creator><creator>Verheijen, René H.M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20060915</creationdate><title>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</title><author>Hermsen, Brenda B.J. ; van Diest, Paul J. ; Berkhof, Johannes ; Menko, Fred H. ; Gille, Johan J.P. ; Piek, Jurgen M.J. ; Meijer, Sybren ; Winters, Henri A.H. ; Kenemans, Peter ; Mensdorff‐Pouilly, Silvia von ; Verheijen, René H.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>BRCA1/2</topic><topic>breast</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - prevention &amp; control</topic><topic>Breast Neoplasms - surgery</topic><topic>Fallopian Tube Neoplasms - genetics</topic><topic>Fallopian Tube Neoplasms - prevention &amp; control</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Genes, BRCA1</topic><topic>Genes, BRCA2</topic><topic>Genetic Predisposition to Disease</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mastectomy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - prevention &amp; control</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Ovariectomy</topic><topic>ovary</topic><topic>premalignant lesions</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermsen, Brenda B.J.</creatorcontrib><creatorcontrib>van Diest, Paul J.</creatorcontrib><creatorcontrib>Berkhof, Johannes</creatorcontrib><creatorcontrib>Menko, Fred H.</creatorcontrib><creatorcontrib>Gille, Johan J.P.</creatorcontrib><creatorcontrib>Piek, Jurgen M.J.</creatorcontrib><creatorcontrib>Meijer, Sybren</creatorcontrib><creatorcontrib>Winters, Henri A.H.</creatorcontrib><creatorcontrib>Kenemans, Peter</creatorcontrib><creatorcontrib>Mensdorff‐Pouilly, Silvia von</creatorcontrib><creatorcontrib>Verheijen, René H.M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermsen, Brenda B.J.</au><au>van Diest, Paul J.</au><au>Berkhof, Johannes</au><au>Menko, Fred H.</au><au>Gille, Johan J.P.</au><au>Piek, Jurgen M.J.</au><au>Meijer, Sybren</au><au>Winters, Henri A.H.</au><au>Kenemans, Peter</au><au>Mensdorff‐Pouilly, Silvia von</au><au>Verheijen, René H.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2006-09-15</date><risdate>2006</risdate><volume>119</volume><issue>6</issue><spage>1412</spage><epage>1418</epage><pages>1412-1418</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>To analyse the prevalence of (pre) malignant lesions occurring in breast and adnexal tissue at prophylactic surgery in women at hereditary high risk of breast and/or ovarian cancers. Tissue was obtained from 85 women who underwent prophylactic bilateral salpingo‐oophorectomy (pBSO) and from 59 women who underwent prophylactic mastectomy (pM). Control tissue samples were obtained from women undergoing breast reduction surgery (N = 99) or adnexal surgery for benign reasons (N = 72). In women with a BRCA1/2 mutation, the prevalence of a (pre) malignant adnexal lesion was 50% (95% CI 26–74) if older than 40 years and 14% (95% CI 0–58) if younger. The prevalences of (pre) malignant breast lesions in women older than 40 years, with and without a BRCA1/2 mutation, were 0% (95% CI 0–16) and 47% (95% CI 21–73), respectively. No association was found between (pre) malignant lesions in breast and adnexal tissue occurring in 28 women who underwent surgery on both organs (R = 0.155, p = 0.432), but the prevalence of lesions was significantly higher in adnexal tissue than in the breast (p = 0.023). Compared to controls, women at hereditary high risk had a higher chance of (pre) malignant lesions in the breast and an even higher chance of such lesions in the adnexal tissue. There was no indication for concomitant presence of such lesions in both organs at the time of prophylactic surgery. The high frequency of (pre) malignant lesions in the adnexal tissue stresses further the importance of pBSO from the age of 40 onwards in women at hereditary high risk. © 2006 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16615107</pmid><doi>10.1002/ijc.21988</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2006-09, Vol.119 (6), p.1412-1418
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_68762931
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Aged
Biological and medical sciences
BRCA1/2
breast
Breast Neoplasms - genetics
Breast Neoplasms - prevention & control
Breast Neoplasms - surgery
Fallopian Tube Neoplasms - genetics
Fallopian Tube Neoplasms - prevention & control
Fallopian Tube Neoplasms - surgery
Female
Female genital diseases
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Gynecology. Andrology. Obstetrics
Humans
Mastectomy
Medical sciences
Middle Aged
Ovarian Neoplasms - genetics
Ovarian Neoplasms - prevention & control
Ovarian Neoplasms - surgery
Ovariectomy
ovary
premalignant lesions
Prevalence
Risk Factors
Tumors
title Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A57%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20prevalence%20of%20(pre)%20malignant%20lesions%20in%20the%20breast%20and%20high%20prevalence%20in%20the%20ovary%20and%20Fallopian%20tube%20in%20women%20at%20hereditary%20high%20risk%20of%20breast%20and%20ovarian%20cancer&rft.jtitle=International%20journal%20of%20cancer&rft.au=Hermsen,%20Brenda%20B.J.&rft.date=2006-09-15&rft.volume=119&rft.issue=6&rft.spage=1412&rft.epage=1418&rft.pages=1412-1418&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.21988&rft_dat=%3Cproquest_cross%3E17241190%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4198-65062b00b0ccc6a6f8d964c540df82923dc4aea5539f67f2af6a128a7c419e5b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17241190&rft_id=info:pmid/16615107&rfr_iscdi=true